PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.

Autor:	Hammond, Flora M.1 Flora.hammond@rhin.com, Alexander, David N.2, Cutler, Andrew J.3, D'Amico, Stephen4, Doody, Rachelle S.5, Sauve, William6, Zorowitz, Richard D.7, Davis, Charles S.8, Shin, Paul9, Ledon, Fred9, Yonan, Charles9, Formella, Andrea E.9, Siffert, Joao9
Zdroj:	BMC Neurology. 6/9/2016, Vol. 16, p1-12. 12p. 2 Diagrams, 3 Charts, 4 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu